Neovascular AMD, accounting for 10–20% of late-stage cases [5], is driven by vascular endothelial growth factor (VEGF) overexpression, which stimulates pathological angiogenesis, resulting in vascular leakage, hemorrhage, or scarring and causing acute vision loss. Here, VEGFA is linked to age-related macular degeneration.